Auragent Bioscience LLC
Plasmonic Fluor nanoconstructs and PFluorospot multiplexed immunoassay platform for single-cell secreted protein detection
- Sector
- Medtech
- Headquarters
- Saint Louis, MO
- Total capital
- $9.6M
- Federal grants
- $9.6M
- 12 awards · 2019–2025
- Rank in peer group#55 of 112
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 9 pending · first 2026
- Rank in peer group#34 of 112
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Low-Cost Platform for Ultrasensitive Fluorescent Immunoblot$982K
- Federal grantHealth and Human S · Phase II · Low-Cost Platform for Ultrasensitive Fluorescent Immunoblot$987K
- Federal grantHealth and Human S · Phase II · High performance and widely accessible secretomics assay platform$787K
- Federal grantHealth and Human S · Phase II · High performance and widely accessible secretomics assay platform$1.7M
- Federal grantHealth and Human S · Phase II · High performance and widely accessible secretomics assay platform$944K
- Federal grantHealth and Human S · Phase II · Ultrabright Fluorescent Nanoconstruct Enabling Widely Accessible, High Performance Multiplexed Protein Assays$808K
- Federal grantHealth and Human S · Phase II · Ultrabright Fluorescent Nanoconstruct Enabling Widely Accessible, High Performance Multiplexed Protein Assays$1.6M
Show 5 earlier federal awards
- Federal grantHealth and Human S · Phase II · Ultrabright Fluorescent Nanoconstruct Enabling Widely Accessible, High Performance Multiplexed Protein Assays$776K
- Federal grantHealth and Human S · Phase I · A High Sensitivity Multiplexed Immunoassay for Aging-Related Inflammation Biomarker Quantification$300K
- Federal grantHealth and Human S · Phase I · A High Sensitivity Multiplexed Immunoassay for Aging-Related Inflammation Biomarker Quantification$300K
- Federal grantHealth and Human S · Phase I · Inexpensive Add-on Plasmonic Patch to Enable Ultrasensitive and High-Dynamic Range Protein Microarrays$197K
- Federal grantHealth and Human S · Phase I · Inexpensive Add-on Plasmonic Patch to Enable Ultrasensitive and High-Dynamic Range Protein Microarrays$197K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 112 peers
Line = medianMedtech · Instrument
- Federal grants#55 · top 49%
- Granted patents#34 · top 30%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 10- PendingUltrabright Fluorescent Nanocomposite Structures For Enhanced Fluorescent BioassaysUSPTOApplication 19442150
- GrantedUltrabright Fluorescent Nanocomposite Structures For Enhanced Fluorescent BioassaysUSPTOUS 12,560,544
- PendingFluorescent Immunoassays Enhanced Using Plasmonic NanostructuresUSPTOApplication PCTUS2023084931
Show all 10 patent records
- Ultrabright Fluorescent Nanocomposite Structures For Enhanced Fluorescent BioassaysJun 4, 2026 · Application 19442150Pending
- Ultrabright Fluorescent Nanocomposite Structures For Enhanced Fluorescent BioassaysFeb 24, 2026 · US 12,560,544Granted
- Fluorescent Immunoassays Enhanced Using Plasmonic NanostructuresApplication PCTUS2023084931Pending
- Chemiluminescent Immunoassays Enhanced Using Plamsonic NanostructuresApplication 63535153Pending
- Fluorescent Immunoassays Enhanced Using Plasmonic NanostructuresApplication 63464897Pending
- Chemiluminescent Immunoassays Enhanced Using Plasmonic NanostructuresApplication PCTUS2024044485Pending
- Ultrabright Fluorescent Nanocomposite Structures For Enhanced Fluorescent BioassaysApplication PCTUS2021015750Pending
- Ultrabright Fluorescent Nanocomposite Structures For Enhanced Fluorescent BioassaysApplication 62968314Pending
- Fluorescent Immunoassays Enhanced Using Plasmonic NanostructuresApplication 19139692Pending
- Chemiluminescent Immunoassays Enhanced Using Plasmonic NanostructuresApplication 19514727Pending
Related companies, and why
- BRIGHTLINE INTERACTIVE LLCSimilar federal contract value in Medtech · null in contracts
- BDI, INC.Similar federal contract value in Medtech · null in contracts
- U-Screen Dx IncSimilar federal contract value in Medtech · null in contracts
- PATHMAKER MOBILITY CORP.Similar federal contract value in Medtech · null in contracts
- CG SCIENTIFIC INCSimilar federal contract value in Medtech · null in contracts
- NANOAFFIX SCIENCE LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .